Sharyn N Lewin, MD
img_Sharyn N Lewin
ASSISTANT CLINICAL PROFESSOR | Obstetrics, Gynecology and Reproductive Science
Are you a patient?
Specialties
Obstetrics and Gynecology, Gynecologic Oncology

MD, University of Kansas School of Medicine

Residency, Obstetrics & Gynecology, Barnes-Jewish Hospital

Fellowship, Gynecologic Oncology, Memorial Sloan-Kettering Cancer Center

Certifications

American Board of Obstetrics and Gynecology
Publications

Selected Publications

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. Christian Marth, Richard G. Moore, Mariusz Bidziński, Sandro Pignata, Ali Ayhan, M. Jesús Rubio, Mario Beiner, Marcia Hall, Christof Vulsteke, Elena Ioana Braicu, Kenzo Sonoda, Xiaohua Wu, Sophia Frentzas, André Mattar, Stephanie Lheureux, Xiaojun Chen, Kosei Hasegawa, Manuel Magallanes-Maciel, Chel Hun Choi, Mariia Shalkova, Diego Kaen, Peng Hui Wang, Regina Berger, Chinyere E. Okpara, Jodi McKenzie, Lili Yao, Robert Orlowski, Vivek Khemka, Lucy Gilbert, Vicky Makker, Diego Lucas Kaen, Gonzalo Gomez Abuin, Liliana Beatriz Zamora, Margarita Sonia Alfie, Ignacio Alfredo Casarini, Michelle Harrison, Sumitra Ananda, Catherine Margaret Shannon, Michael Friedlander, Tarek Meniawy, Bo Gao, Sally Baron-Hay, Connie Diakos, Stephan Polterauer, Edgar Petru, Marlies De Bock, Jean Francois Baurain, Toon Van Gorp, Sharyn Lewin, Stephanie Blank. Journal of Clinical Oncology

The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial. A. Alvarez Secord, S. N. Lewin, C. G. Murphy, S. C. Cecere, A. Barquín, F. Gálvez-Montosa, C. A. Mathews, G. E. Konecny, I. Ray-Coquard, A. Oaknin, M. J. Rubio Pérez, A. Bonaventura, E. J. Diver, S. M. Ayuk, Y. Wang, B. R. Corr, V. Salutari. Annals of Oncology

Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer. David M. O'Malley, Tashanna Myers, Pauline Wimberger, Toon Van Gorp, Andres Redondo, David Cibula, Shibani Nicum, Manuel Rodrigues, Floor J. Backes, Joyce N. Barlin, Sharyn N. Lewin, Peter Lim, Bhavana Pothuri, Elisabeth Diver, Susana Banerjee, Domenica Lorusso. Future Oncology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Lewin has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.